In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

MediGene acquires NeuroVir Therapeutics in stock swap

Executive Summary

MediGene (cardiac therapeutics and cancer vaccines) has acquired cancer therapeutics company NeuroVir Therapeutics in a stock swap. MediGene has issued about 997k new shares in exchange for the 91% of the company it did not own.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register